<code id='4C98E9A379'></code><style id='4C98E9A379'></style>
    • <acronym id='4C98E9A379'></acronym>
      <center id='4C98E9A379'><center id='4C98E9A379'><tfoot id='4C98E9A379'></tfoot></center><abbr id='4C98E9A379'><dir id='4C98E9A379'><tfoot id='4C98E9A379'></tfoot><noframes id='4C98E9A379'>

    • <optgroup id='4C98E9A379'><strike id='4C98E9A379'><sup id='4C98E9A379'></sup></strike><code id='4C98E9A379'></code></optgroup>
        1. <b id='4C98E9A379'><label id='4C98E9A379'><select id='4C98E9A379'><dt id='4C98E9A379'><span id='4C98E9A379'></span></dt></select></label></b><u id='4C98E9A379'></u>
          <i id='4C98E9A379'><strike id='4C98E9A379'><tt id='4C98E9A379'><pre id='4C98E9A379'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:257

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Biden's 'march
          Biden's 'march

          Sen.BillCassidy(R-La.)KevinDietsch/GettyImagesWASHINGTON—RepublicansinCongressmighttrytouseatechnica

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Anthos stroke drug appears safer than common blood thinner

          AdobePHILADELPHIA—Aninvestigationaldrugaimedatpreventingstrokessignificantlyreducedtheriskofbleeding